🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04113044
Active, not recruiting Observational

Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®

NCT04113044 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2021-02-01
Last updated
2026-03-06

Condition(s) studied

Hip FracturesTibial FracturesAnkle FracturesHumeral Fracture, ProximalDistal Radius Fracture

Investigational drug(s) / intervention(s)

All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.: All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

Study summary

Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups).

Patients will be followed up according to the standard (routine) for up to 1 year after the treatment.

Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years and older * Diagnosis of one of, isolated injury * Hip fracture * Tibial shaft fracture (with and without associated fibular fracture) * Ankle/pilon fracture * Proximal humerus fracture * Distal radius fracture * English, German, or Spanish speaking * Informed consent obtained, i.e.: * Ability to understand the content of the patient information/ICF * Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP) * Signed and dated EC/IRB approved written informed consent Exclusion Criteria: * More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision * Patients with multiple fractures * Pathological fractures due to cancer * Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment * Pregnancy or women planning to conceive within the study period * Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place * Prisoners * Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study * Patients unable to likely achieve anticipated Follow-up (FU)

Primary outcome measure(s)

Trial sites (15)

FacilityCityRegionStatus
Cedars-Sinai Department of Orthopaedics Los Angeles California
University of Miami, Jackson Memorial Hospital Ryder Trauma Center Miami Florida
Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative Boston Massachusetts
The Value Institute / Department of Surgery and Peri-operative Care. Dell Medical School, University of Texas at Austin Austin Texas
Univ.-Klinik für Orthopädie und Traumatologie Innsbruck Austria
Fundación Santa Fe de Bogotá Bogotá Colombia
Centrum für Muskuloskeletale Chirurgie (CMSC) Charite - Universitätsmedizin Berlin Berlin Germany
University Hospital Freiburg Freiburg im Breisgau Germany
Saarland University Hospital Department of Trauma, Hand and Reconstructive Surgery Homburg Germany
Institut für Biomechanik Berufsgenossenschaftliche Unfallklinik Murnau Murnau am Staffelsee Germany
Abteilung für Unfall- und Wiederherstellungschirurgie BG Klinik Tübingen Tübingen Germany
University Medical Center Groningen Groningen Netherlands
Isala Clinics Zwolle Netherlands
Barts Health NHS Trust London United Kingdom
Oxford University Hospitals NHS Foundation Trust Oxford United Kingdom

More AO Innovation Translation Center trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04113044 on ClinicalTrials.gov ↗ ← All trials in Germany